Literature DB >> 25664796

Structural analysis of human dual-specificity phosphatase 22 complexed with a phosphotyrosine-like substrate.

George T Lountos1, Scott Cherry2, Joseph E Tropea2, David S Waugh2.   

Abstract

4-Nitrophenyl phosphate (p-nitrophenyl phosphate, pNPP) is widely used as a small molecule phosphotyrosine-like substrate in activity assays for protein tyrosine phosphatases. It is a colorless substrate that upon hydrolysis is converted to a yellow 4-nitrophenolate ion that can be monitored by absorbance at 405 nm. Therefore, the pNPP assay has been widely adopted as a quick and simple method to assess phosphatase activity and is also commonly used in assays to screen for inhibitors. Here, the first crystal structure is presented of a dual-specificity phosphatase, human dual-specificity phosphatase 22 (DUSP22), in complex with pNPP. The structure illuminates the molecular basis for substrate binding and may also facilitate the structure-assisted development of DUSP22 inhibitors.

Entities:  

Keywords:  4-nitrophenyl phosphate; dual-specificity phosphatase 22

Mesh:

Substances:

Year:  2015        PMID: 25664796      PMCID: PMC4321476          DOI: 10.1107/S2053230X15000217

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  46 in total

Review 1.  Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.

Authors:  Zhong-Yin Zhang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  ExPASy: The proteomics server for in-depth protein knowledge and analysis.

Authors:  Elisabeth Gasteiger; Alexandre Gattiker; Christine Hoogland; Ivan Ivanyi; Ron D Appel; Amos Bairoch
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  Matthews coefficient probabilities: Improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystals.

Authors:  Katherine A Kantardjieff; Bernhard Rupp
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

4.  Expression, purification, and physicochemical characterization of a recombinant Yersinia protein tyrosine phosphatase.

Authors:  Z Y Zhang; J C Clemens; H L Schubert; J A Stuckey; M W Fischer; D M Hume; M A Saper; J E Dixon
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

5.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

6.  Rhodanine derivatives as inhibitors of JSP-1.

Authors:  Neil S Cutshall; Christine O'Day; Marina Prezhdo
Journal:  Bioorg Med Chem Lett       Date:  2005-07-15       Impact factor: 2.823

7.  Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency.

Authors:  R B Kapust; J Tözsér; J D Fox; D E Anderson; S Cherry; T D Copeland; D S Waugh
Journal:  Protein Eng       Date:  2001-12

8.  Activation of the Jnk signaling pathway by a dual-specificity phosphatase, JSP-1.

Authors:  Y Shen; R Luche; B Wei; M L Gordon; C D Diltz; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

9.  Structural basis for the recognition of a bisphosphorylated MAP kinase peptide by human VHR protein Phosphatase.

Authors:  Maria A Schumacher; Jacob L Todd; Adrian E Rice; Kirk G Tanner; John M Denu
Journal:  Biochemistry       Date:  2002-03-05       Impact factor: 3.162

Review 10.  Protein tyrosine phosphatases in the human genome.

Authors:  Andres Alonso; Joanna Sasin; Nunzio Bottini; Ilan Friedberg; Iddo Friedberg; Andrei Osterman; Adam Godzik; Tony Hunter; Jack Dixon; Tomas Mustelin
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

View more
  3 in total

1.  Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia.

Authors:  M P Boks; L C Houtepen; Z Xu; Y He; G Ursini; A X Maihofer; P Rajarajan; Q Yu; H Xu; Y Wu; S Wang; J P Shi; H E Hulshoff Pol; E Strengman; B P F Rutten; A E Jaffe; J E Kleinman; D G Baker; E M Hol; S Akbarian; C M Nievergelt; L D De Witte; C H Vinkers; D R Weinberger; J Yu; R S Kahn
Journal:  NPJ Schizophr       Date:  2018-08-21

2.  Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-α inhibitor in Crohn disease patients.

Authors:  Xue Shi; Wei Yang; Nian Wang; Junyi Zhu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

3.  Structural Insights into the Active Site Formation of DUSP22 in N-loop-containing Protein Tyrosine Phosphatases.

Authors:  Chih-Hsuan Lai; Co-Chih Chang; Huai-Chia Chuang; Tse-Hua Tan; Ping-Chiang Lyu
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.